ITCI: Intra-Cellular Therapies, Inc. Company Cash Volume

Official company branding of Intra-Cellular Therapies, Inc. (ITCI)

Intra-Cellular Therapies (ITCI) is actively scaling its distribution driven by the demand for polar depression therapy. The company's free cash flow illustrates its balance sheet liquidity, while 1.00 marks a new level. Growth is supported by Caplyta sales and the expansion of insurance coverage, while the environmental strategy is based on the implementation of "green chemistry" for the safe disposal of laboratory reagents.

Company Cash Balance: Intra-Cellular Therapies, Inc. (ITCI) for 07/04/2022 - 04/13/2025

Comprehensive metric breakdowns and analytics for Intra-Cellular Therapies (ITCI)

Fundamental valuation:Intra-Cellular Therapies, Inc.
Product sample of Intra-Cellular

Intra-Cellular Therapies (ITCI) is investing in the promotion of Caplyta to transform the treatment of psychiatric disorders. By analyzing cash dynamics, the investor gains a real-time assessment of liquidity without quarterly delays. This metric captures the volume of available funds for operational management and R&D. A sufficient resource reserve guarantees financial stability during the commercialization of molecules, although excess cash may signal low capital efficiency.

Competitors of Intra-Cellular Therapies (ITCI)

Company Cash Volume BIIB|Company Cash Funds NBIX (Neurocrine Biosciences)|Company Cash Funds Regencell Bioscience Ltd RGC|AXSM (Axsome Therapeutics, Inc.) - Company Total Cash Volume|ACADIA Corp - Company Cash Volume|Company Cash Reserve Xenon Pharmaceuticals|VKTX (Viking Therapeutics Corp) - Company Cash on Hand|Supernus Pharmaceuticals (SUPN) - Company Cash Volume|CPRX (Catalyst Pharma) - Company Cash Volume|DNLI (Denali Therapeutics Inc.) - Company Total Cash Amount|Company Cash Volume HRMY|Biohaven Corp - Company Cash and Cash Equivalents|Company Cash Volume AMLX (amylyx.com)|Company Liquid Assets Trevi Therapeutics, Inc. (TRVI)|Praxis Corp - Company Cash Volume|Company Cash Reserve Anavex|CBLL (CeriBell Inc) - Company Cash on Hand|Company Cash and Cash Equivalents PRTA|Company Cash Funds Alector Inc.|Company Cash Reserve Annexon, Inc. ANNX|Company Cash Funds Omeros Corp (OMER)|NGNE (Neurogene Inc) - Company Cash Balance|Company Cash Funds AC Immune Inc ACIU|Company Cash Position Voyager Corp|Neumora Corp - Company Cash Volume|scilexholding.com (SCLX) - Company Cash on Hand|Tevogen Bio Holdings, Inc. (TVGN) - Company Cash Funds|Alpha Cognition Corp (ACOG) - Company Cash Volume|Company Cash on Hand CGTX|Company Cash and Cash Equivalents IKT (Inhibikase)|Company Cash Volume SAVA|Assertio - Company Cash and Cash Equivalents|Company Cash Volume COYA (Coya Therapeutics)|Company Cash Volume Vistagen Therapeutics VTGN|OVID: Company Cash on Hand|ABOS - Company Cash Volume|CRVO: Company Cash Volume|Company Cash Reserve Alterity Therapeutics Ltd. (ATHE)|Company Cash Funds Clene Inc.|pepgen.com (PEPG) - Company Liquid Assets|Company Cash on Hand JUNS (jupiterneurosciences.com)|Company Cash Funds RLMD (Relmada Corp)|Annovis Bio, Inc. - Company Cash on Hand|Company Cash Position Grace Therapeutics, Inc.|Firefly Neuroscience, Inc - Company Cash Volume|KLTO - Company Cash Volume|NRSN (NeuroSense Therapeutics Ltd.) - Company Cash on Hand|RVPH - Company Liquid Assets|Company Cash Funds MetaVia|Company Cash and Cash Equivalents NRXS (neuraxis.com)|Company Cash Funds Helius Medical Technologies (HSDT)|PASG (Passage Bio) - Company Cash Balance|Company Cash Volume NEUP (Neuphoria Therapeutics)|Company Cash Balance NERV|ATHA - Company Cash Funds|Company Total Cash Volume ADXN|ALZN (Alzamend Neuro) - Company Cash on Hand|Company Cash and Cash Equivalents CYCN|PTIX (Protagenic Therapeutics, Inc.) - Company Cash Volume|KTTA: Company Cash Balance|Company Cash Funds Cortigent Medical (CRGT)|ATXI - Company Cash Reserve|Company Cash Volume BCLI (Brainstorm Cell Therapeutics Inc.)|Cara Therapeutics, Inc (CARA) - Company Cash Reserve|CHRO: Company Cash on Hand|Eliem Therapeutics Inc. (ELYM) - Company Cash on Hand|Longboard Pharma (LBPH) - Company Cash Funds|Company Cash on Hand Marinus Pharmaceuticals|Company Cash Funds NKGen|Company Cash Volume NeuroBo Pharmaceuticals, Inc.|Company Cash Volume SAGE|Synaptogenix, Inc - Company Cash and Cash Equivalents|Company Cash Funds Trevena TRVN|Company Cash Position Vigil Neuroscience|Anew Medical Inc. - Company Cash Volume|Company Liquid Assets Cerevel Therapeutics, Inc. CERE